The effects of ACE inhibitor and angiotensin receptor blocker on clusterin and apoptosis in the kidney tissue of streptozotocin-diabetic rats

Journal of Molecular Histology

Volumn 39, Issue 6, 2008, Pages 605-616

  Tunçdemir, Matem ^a   Ozturk, Melek ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Apoptosis; Clusterin; Kidney; STZ diabetes; TGF

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CLUSTERIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; IRBESARTAN; PERINDOPRIL; TRANSFORMING GROWTH FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; GLUCOSE BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RAT; RENAL PROTECTION; STREPTOZOCIN DIABETES;

ACTINS; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; APOPTOSIS; BLOOD GLUCOSE; BODY WEIGHT; CLUSTERIN; DIABETES MELLITUS, EXPERIMENTAL; IN SITU NICK-END LABELING; KIDNEY; MALE; PROTEIN ISOFORMS; RATS; RATS, WISTAR; TRANSFORMING GROWTH FACTOR BETA;

RATTUS;

EID: 56349091404     PISSN: 15672379     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10735-008-9201-2     Document Type: Article

References (46)

1. B Antus I Mucsi L Rosivall 2000 Apoptosis induction and inhibition of cellular proliferation by angiotensin II: possible implication and perspectives Acta Physiol Hung 87 1 5 24 10.1556/APhysiol.87.2000.1.2
2. S Bamri-Ezzine ZJ Ao I Londono 2003 Apoptosis of tubular epithelial cells in glycogen nephrosis during diabetes Lab Invest 83 1069 1080 10.1097/01.LAB.0000078687.21634.69
3. S Barut YA Unlu A Karaoglan 2005 The neuroprotective effects of z-DEVD. fmk, a caspase-3 inhibitor, on traumatic spinal cord injury in rats Surg Neurol 64 3 213 220 10.1016/j.surneu.2005.03.042
4. F Bonnet ME Cooper H Kawachi 2001 Irbesartan normalises the deficiency in glomerular nephrin expression in a model of diabetes and hypertension Diabetologia 44 874 877 10.1007/s001250100546
5. EP Böttinger 2007 TGF-beta in renal injury and disease Semin Nephrol 27 3 309 320 10.1016/j.semnephrol.2007.02.009
6. MH Branton JB Kopp 1999 TGF-B and fibrosis Microbes Infect 1 1349 1365 10.1016/S1286-4579(99)00250-6
7. RL Chevalier S Goyal JT Wolstenholme 1998 Obstructive nephropathy in the neonatal rat is attenuated by epidermal growth factor Kidney Int 54 1 38 47 10.1046/j.1523-1755.1998.00966.x
8. S Dhein S Hochreuther CAD Spring 2000 Long-term effects of the endothelin A receptor antagonist LU 135252 and the angiotensin-converting enzyme inhibitor trandolapril on diabetic angiopathy and nephropathy in a chronic type 1 diabetes mellitus rat model J Pharmacol Exp Ther 293 351 359
9. G Ding K Reddy AA Kapasi 2002 Angiotensin II induces apoptosis in rat glomerular epithelial cells Am J Physiol Renal Physiol 283 173 180
10. KA Duggan G Hodge MM Makarious 1998 Renoprotective differences between perindopril and enalapril in the diabetic hypertensive rat do not reflect glomerular angiotensin-converting enzyme activity Clin Sci 94 511 516
11. AM El Nahas 2003 Plasticity of kidney cells: role in kidney remodeling and scarring Kidney Int 64 1553 1563 10.1046/j.1523-1755.2003.00255.x
12. N Erensoy S YIlmazer M Ozturk 2004 Effects of ACE inhibition on the expression of type IV collagen and laminin in renal glomeruli in experimental diabetes Acta Histochem 106 279 287
13. A Flyvbjerg 2000 Putative pathophysiological role of growth factors and cytokines in experimental diabetic kidney disease Diabetologia 43 10 1205 1223 10.1007/s001250051515
14. RE Gilbert A Cox LL Wu 1998 Expression of transforming growth factor-ß1 and type IV collagen in the renal tubulointerstitium in experimental diabetes Diabetes 47 414 422 10.2337/diabetes.47.3.414
15. C Hill A Flyvbjerg H Gronbeak 2000 The renal expression of transforming growth factor-β isoforms and their receptors in acute and chronic experimental diabetes in rats Endocrinology 141 1196 1208 10.1210/en.141.3.1196
16. SE Jones C Jomary 2002 Molecules in focus clusterin Int J Biochem Cell Biol 34 427 431 10.1016/S1357-2725(01)00155-8
17. B Kalender M Öztürk M Tunçdemir 2002 Renoprotective effects of valsartan and enalapril in STZ-induced diabetes in rats Acta Histochem 104 2 123 130 10.1078/0065-1281-00643
18. DJ Kelly AJ Cox M Tolcos 2002 Attenuation of tubular apoptosis by blockade of the renin-angiotensin system in diabetic Ren-2 rats Kidney Int 61 31 39 10.1046/j.1523-1755.2002.00088.x
19. JH Kim BK Kim KC Moon 2003 Activation of the TGF-β/Smad signalling pathway in focal segmental glomerulosclerosis Kidney Int 64 1715 1721 10.1046/j.1523-1755.2003.00288.x
20. MJA Kocks D Zeeuw GJ Navis 2002 Optimal blood pressure control and antihypertensive regimens in hypertensive renal disease: the potential of exploring the mechanism of response variability Curr Opin Nephrol Hypertens 1 135 140 10.1097/00041552-200203000-00002
21. D Kumar J Zimpelmann S Robertson 2004 Tubular and interstitial cell apoptosis in the streptozotocin-diabetic rat kidney Nephron Exp Nephrol 96 3 77 88 10.1159/000076749
22. J Lakins SA Bennett JH Chen 1998 Clusterin biogenesis is altered during apoptosis in the regressing rat ventral prostate J Biol Chem 273 43 27887 27895 10.1074/jbc.273.43.27887
23. KS Leskov DY Klokov J Li 2003 Synthesis and functional analyses of nuclear clusterin, a cell death protein J Biol Chem 278 13 590 600 10.1074/jbc.M209233200
24. BC Liu Q Chen DD Luo 2003 Mechanisms of irbesartan in prevention of renal lesion in streptozotocin-induced diabetic rats Acta Pharmacol Sin 24 1 67 73
25. SA Mifsud SL Skinner ME Cooper 2002 Effects of low-dose and early versus late perindopril treatment on the progression of severe diabetic nephropathy in (mREN-2) 27 rats J Am Soc Nephrol 13 684 692
26. A Ortiz 2000 Apoptotic regulatory proteins in renal injury Kidney Int 58 467 485 10.1046/j.1523-1755.2000.00188.x
27. A Ortiz FN Ziyadeh EG Neilson 1997 Expression of apoptosis-regulatory genes in renal proximal tubular epithelial cells exposed to high ambient glucose and in diabetic kidneys J Investig Med 45 2 50 56
28. ME Rosenberg J Silkensen 1995 Clusterin: physiologic and pathophysiologic considerations J Biochem Cell Biol 27 633 645 10.1016/1357-2725(95)00027-M
29. ME Rosenberg R Girton D Finkel 2002 Apolipoprotein J/clusterin prevents a progressive glomerulopathy of aging Mol Cell Biol 22 1893 1902 10.1128/MCB.22.6.1893-1902.2002
30. M Ruiz-Ortega O Lorenzo M Ruperez 2001 Role of the renin-angiotensin system in vascular diseases: expanding the field Hypertension 38 6 1382 1387 10.1161/hy1201.100589
31. T Sanai T Sobka T Johnson 2000 Expression of cytoskeletal proteins during the course of experimental diabetic nephropathy Diabetologia 43 1 91 100 10.1007/s001250050012
32. A Sauter K Machura B Neubauer 2008 Development of renin expression in the mouse kidney Kidney Int 73 43 51 10.1038/sj.ki.5002571
33. LA Stephenson LB Haney IM Hussaini 1998 Regulation of smooth muscle α-actin expression and hypertrophy in cultured mesangial cells Kidney Int 54 1175 1187 10.1046/j.1523-1755.1998.00101.x
34. JE Toblli G Drosa G Cao 2004 ACE inhibitor and angiotensin type I receptor antagonist in combination reduce damage in obese zucker rats Kidney Int 65 2343 2359 10.1111/j.1523-1755.2004.00661.x
35. IP Trougakos ES Gonos 2002 Clusterin/apolipoprotein J in human aging and cancer Int J Biochem Cell Biol 34 1430 1448 10.1016/S1357-2725(02)00041-9
36. IP Trougakos M Lourda G Agiostratidou 2005 Differential effects of clusterin/apolipoprotein J on cellular growth and survival Free Radic Biol Med 38 436 449 10.1016/j.freeradbiomed.2004.10.038
37. V Wang A Tzanidis M DIvjak 2001 Altered signalling and regulatory mechanisms of apoptosis in focal and segmental glomerulosclerosis J Am Soc Nephrol 12 1422 1433
38. JL Wilkinson-Berka NJ Gibbs ME Cooper 2001 Renoprotective and anti-hypertensive effects of combined valsartan and perindopril in progressive diabetic nephropathy in the transgenic (mRen-2) 27 rat Nephrol Dial Transplant 16 1343 1349 10.1093/ndt/16.7.1343
39. G Wolf 2004 New insights into the pathophysiology of diabetic nephropathy: from haemodynamics to molecular pathology Eur J Clin Invest 34 12 785 796 10.1111/j.1365-2362.2004.01429.x
40. K Yamada Y Hori N Hanafusa 2001 Clusterin is up-regulated in glomerular mesangial cells in complement-mediated injury Kidney Int 59 137 146 10.1046/j.1523-1755.2001.00474.x
41. L Yan R Yang H Cheng 1998 Protective effect of the angiotensin-converting enzyme inhibitor perindopril on diabetic glomerulopathy in streptozotocin- induced diabetic rats Chin Med J (Engl) 111 4 306 308
42. KH Yoo AT Barbara 1998 Tissue specific regulation of growth factors and clusterin by angiotensin II Am J Hypertens 11 715 722 10.1016/S0895-7061(98) 00018-1
43. G Zhang P Khanna LL Chan 1997 Diabetes-induced apoptosis in rat kidney Biochem Mol Med 61 58 62 10.1006/bmme.1997.2592
44. H Zhang JK Kim CA Edwards 2005 Clusterin inhibits apoptosis by interacting with activated Bax Nat Cell Biol 7 909 915 10.1038/ncb1291
45. FA Ziyadeh K Sharma M Ericksen 1994 Stimulation of collagen gene expression and protein synthesis in murine mesengial cells by high glucose is mediated by autocrine activation of transforming growth factor-β J Clin Invest 93 536 542 10.1172/JCI117004
46. FN Ziyadeh S Goldfarb 1991 The renal tubulointerstitium in diabetes mellitus Kidney Int 39 464 475 10.1038/ki.1991.57